Harvard Bioscience Long Term Deferred Assets (Quarterly) Insights

Harvard Bioscience, Inc. (HBIO)

0.5872 +0.01 (+1.29%) USD | NASDAQ | Jan 16, 16:00

0.58 -0.01 (-1.23%) Pre-Market: 09:09

View Long Term Deferred Assets (Quarterly) for HBIO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Bruker Corp.	--
Azenta, Inc.	Upgrade
Precipio, Inc.	--
Bionano Genomics, Inc.	--
Kestra Medical Technologies Ltd.	--